Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04464954 · ClinicalTrials.gov registry record · NA
BFA Treatment of Pain
A NA study, sponsored by Paul Crawford.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04464954 is a NA study that has completed, run by Paul Crawford. The registered enrollment target is 30 participants.
The verdict
NCT04464954, a NA study, has completed, sponsored by Paul Crawford.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The aim of this pilot study is to conduct an unblinded pilot randomized clinical study on the effectiveness and tolerability of auricular semi-permanent (ASP) vs intradermal (long), and pyonex needles in Battlefield Acupuncture (BFA) for the treatment of pain.
Interventions
- DEVICE Auricular semi-permanent (ASP gold) needles
- DEVICE Intradermal (long) needles using J-type No. 2 (.18)x 15mm
- DEVICE Pyonex needles (Seirin Yellow 0.2 x 0.6mm)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2021-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04464954
The ClinicalTrials.gov registry entry for NCT04464954 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paul Crawford, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Auricular semi-permanent (ASP gold) needles is the first listed.
NCT04464954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04464954 about?
NCT04464954 is a clinical study titled "BFA Treatment of Pain". The aim of this pilot study is to conduct an unblinded pilot randomized clinical study on the effectiveness and tolerability of auricular semi-permanent (ASP) vs intradermal (long), and pyonex needles in Battlefield Acupuncture (BFA) for the treatment of pain.
What is the current status of trial NCT04464954?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-11-01. Estimated completion is 2021-04-20.
What interventions are being tested in trial NCT04464954?
The interventions under investigation include: Auricular semi-permanent (ASP gold) needles (DEVICE), Intradermal (long) needles using J-type No. 2 (.18)x 15mm (DEVICE), Pyonex needles (Seirin Yellow 0.2 x 0.6mm) (DEVICE).
Who is sponsoring clinical trial NCT04464954?
This trial is sponsored by Paul Crawford, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.